...
首页> 外文期刊>Neoplasia: an international journal for oncology research >Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway 1 2 3
【24h】

Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway 1 2 3

机译:蛋白磷酸酶1调节亚基SDS22通过充当AKT信号通路的负调节剂来抑制乳腺癌细胞的发生。 1 < sup> 2 3 < / sup>

获取原文
           

摘要

Protein phosphatases play a crucial role in cell cycle progression, cell survival, cellular signaling, and genomic integrity. The protein phosphatase 1 (PP1) regulatory subunit SDS22 plays a significant role in cell cycle progression. A recent study showed that SDS22 plays a vital role in epithelial integrity and tumor suppression in Drosophila. However, its tumor suppressive activity remains obscure in the mammalian system. Here, for the first time, we show that SDS22 inhibits the growth of breast cancer cells through induction of apoptosis. SDS22 negatively regulates the AKT kinase signaling pathway through PP1. SDS22 associates predominantly with AKT and dephosphorylates the phospho Thr308 and phospho Ser473 through PP1 and hence abrogates the cell migration, invasion, and tumor growth. Thus, our study deciphers the long-standing question of how PP1 negatively regulates the AKT signaling pathway. Further, we observed a significant converse correlation in the expression levels of SDS22 and phospho form of AKT with reduced levels of SDS22 in the higher grades of cancer. Overall, our results suggest that SDS22 could be a putative tumor suppressor and replenishment of SDS22 would be an important strategy to restrict the tumor progression.
机译:蛋白质磷酸酶在细胞周期进程,细胞存活,细胞信号传导和基因组完整性中起着至关重要的作用。蛋白质磷酸酶1(PP1)调节亚基SDS22在细胞周期进程中起着重要作用。最近的一项研究表明,SDS22在果蝇的上皮完整性和肿瘤抑制中起着至关重要的作用。但是,其抑癌活性在哺乳动物系统中仍然不清楚。在这里,我们首次展示了SDS22通过诱导凋亡来抑制乳腺癌细胞的生长。 SDS22通过PP1负调控AKT激酶信号传导途径。 SDS22主要与AKT缔合,并通过PP1使磷酸化Thr308和磷酸化Ser473脱磷酸化,从而消除了细胞迁移,侵袭和肿瘤生长。因此,我们的研究破译了PP1如何负调节AKT信号通路的长期存在的问题。此外,我们观察到在较高等级的癌症中,SDS22和磷酸化AKT的表达水平与SDS22的水平降低呈显着的逆相关。总体而言,我们的结果表明,SDS22可能是推定的肿瘤抑制因子,补充SDS22将是限制肿瘤进展的重要策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号